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Abstract: 
Objective: To examine the efficacy of microcurrent electrical neuromuscular stimulation 
(MENS) treatment on pain and loss of range of motion (ROM) associated with delayed-onset 
muscle soreness (DOMS). 
 
Design and Setting: We assigned subjects to 1 of 2 groups. Group 1 received treatment with 
microcurrent stimulation (200 µA, 30 Hz, for 10 minutes, then 100 µA, 0.3 Hz, for 10 minutes) 
24, 48, and 72 hours after DOMS induction. Group 2 served as a sham group and was treated 
using a machine altered by the manufacturer so that no current could flow through the electrodes. 
 
Subjects: DOMS was induced in the biceps brachii of the nondominant arm of 18 subjects (3 
males, 15 females: age = 20.33 ± 2.3 years, ht = 170.81 ± 7.3 cm, wt = 69.61 ± 13.1 kg). 
Dominance was defined as the arm used by the subject to throw a ball. 
 
Measurements: Subjective pain and active elbow extension ROM were evaluated before and 
after treatment each day. Two methods were used to assess pain: constant pressure using a 
weighted Orthoplast sphere and full elbow extension to the limit of pain tolerance. Subjective 
pain was measured with a graphic rating scale and active elbow extension ROM using a 
standard, plastic, double-armed goniometer. Three repeated-measures ANOVAs (between-
subjects variable was group, within-subjects variables were day and test) were used to assess 
ROM and pain scores for the 2 groups. 
 
Results: We found no significant difference in the measurement of subjective pain scores or 
elbow extension ROM when the MENS group was compared with the sham group. 
 
Conclusions: Our results indicate that the MENS treatment, within the parameters used for this 
experiment, was not effective in reducing the pain or loss of ROM associated with delayed-onset 
muscle soreness. 
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Article: 
Electrical stimulation is a modality frequently used by athletic trainers in the treatment of 
symptoms (such as pain, swelling, loss of range of motion [ROM], and spasm) that are 
commonly associated with musculoskeletal trauma.
1
 Recently, microcurrent stimulation has 
received attention as another type of electrotherapeutic modality capable of providing the 
beneficial effects commonly associated with the more classical forms of electrical stimulation.
2
 
Microcurrent electrical neuromuscular stimulation (MENS) is a subsensory modality that 
employs current intensities between 1 and 999 µA. It has been successfully used to enhance soft 
tissue healing
3-5 
and to treat fracture nonunions.
6
 The efficacy of microcurrent stimulation in the 
treatment of these conditions has led some clinicians to suggest that it might also be valuable in 
the treatment of musculoskeletal injury. Although MENS is used in the sports medicine setting, 
controlled, scientific studies documenting its efficacy are lacking. The purpose of our study was 
to examine the effect of microcurrent stimulation on pain and decreased ROM associated with 
delayed-onset muscle soreness (DOMS) using a double-blind research design. 
 
METHODS  
Subjects 
Eighteen subjects (3 males, 15 females: age = 20.33 ± 2.3 years, ht = 170.81 ± 7.3 cm, wt = 
69.61 ± 13.1 kg) volunteered to participate in this study. None of the subjects were involved in 
any type of weight-lifting regimen. Subjects were asked to avoid any treatment other than the 
prescribed microcurrent treatment during their participation in the study. The procedures for this 
study were approved by a university institutional review board, and each subject provided 
informed consent. 
 
Procedures 
We assigned subjects to 1 of 2 groups. Group I served as the treatment group and received 
microcurrent stimulation (MENS 2000, Monad Corp, Pomona, CA). Group 2 served as the sham 
group and received treatment from a microcurrent unit that had been disabled by the 
manufacturer to provide no electrical stimulation. During the initial testing session, we assessed 
subjects for pain and elbow extension ROM. After this initial assessment, DOMS was induced. 
Subjects returned at 24-hour intervals for 3 days (days 2 through 4). 
 
To ensure the blind nature of the study, neither experimenters nor subjects knew which 
microcurrent unit was the sham unit until the study was completed. Also, we asked subjects to 
refrain from commenting on any sensations experienced during treatment unless they felt pain or 
discomfort. 
 
Range of Motion 
We measured active elbow extension ROM using a standard, plastic, double-armed goniometer 
(Jamar, Clifton, NJ) with the subjects supine on a table and a towel roll just proximal to the 
elbow of the affected arm. The goniometer was aligned proximally with the head of the humerus 
and distally with the radial styloid. Elbow ROM was measured as subjects extended their elbows 
into a relaxed position. 
 
Delayed-Onset Muscle Soreness 
After initial evaluation for pain and ROM, DOMS was induced in the nondominant biceps 
brachii of each subject. The protocol for inducing DOMS has been previously described and 
proved effective.
7-12
 Male subjects began with a 13.5-kg (30-1b) dumbbell, whereas female 
subjects began with an 11.25-kg (25-1b) dumbbell. Beginning in full elbow flexion, subjects 
were instructed to lower the dumbbell to full extension over 3 seconds. Upon reaching full 
extension, the primary investigator assisted the subjects in returning the weight to the starting 
position. Subjects performed continuous repetitions until they could no longer control the weight 
during the 3-second period. At this point, the weight was reduced by 2.25 kg (5 lb), and the 
protocol was repeated. As subjects continued to fatigue, the weight was sequentially lowered in 
2.25-kg (5-1b) increments until a total weight of 2.25 kg (5 lb) was reached. At this weight, 
subjects were asked to perform repetitions either to fatigue or until 10 repetitions were 
completed. 
 
Treatment 
Subjects returned to the testing site 24, 48, and 72 hours after the initial treatment session. A 5.08 
X 10.16-cm (2 X 4-in) pad was attached to the positive electrode and placed over the belly of the 
biceps brachii. A 5.08 X 5.08-cm (2 X 2-in) pad was placed posteriorly over the belly of the 
triceps brachii. Subjects received a 20-minute treatment. For those subjects receiving the MENS 
treatment, the intensity for the first 10 minutes was set at 200 µA and the frequency at 30 Hz. 
After 10 minutes, the intensity and frequency were lowered to 100 µA and 0.3 Hz, respectively. 
 
 
 
Pain Assessment 
Pain was assessed using a graphic rating scale (GRS).
13
 The scale consisted of a horizontal axis 
with verbal descriptors of pain intensity placed at equal distances along the length (Figure 1). 
Subjects were asked to place a vertical line at the point on the scale that best described their pain. 
The distance from the left side of the scale to this mark was measured in centimeters. 
Pain was elicited in 2 ways. For the first pain measurement, pain was recorded as constant 
pressure was exerted on the belly of the muscle. A 5.08-cm (2-in) diameter sphere constructed 
from Orthoplast (Johnson & Johnson, Pittsburgh, PA) was glued to a 10 X 10-cm (4 X 4-in) 
square of the same material (Figure 2). A 2.25-kg (5-1b) ankle weight was attached to the 
Orthoplast sphere. After pilot testing, a 2.25-kg (5-1b) ankle weight was found to have adequate 
mass to elicit discomfort. Each subject was seated with the arm resting on a table at 90° of 
horizontal shoulder abduction and 90° of elbow flexion. The Orthoplast sphere was looped over 
the belly of the biceps brachii, and the subject was asked to rate pain while the weight rested on 
the arm. For the second pain measurement, each subject was asked to rate pain while actively 
extending the elbow as far as possible. To limit the potential influence of pain, this measurement 
was taken after elbow extension ROM. Pain measurements were taken before and after DOMS 
induction and before and after treatment during subsequent sessions. 
 
 
RESULTS 
Three repeated-measures analyses of variance (the between- subjects variable was group and the 
within-subjects variables were day and test) were used to assess ROM and pain scores for the 2 
groups. Increased ROM and decreased pain score indicate improvement after the treatment. 
Means and standard deviations for all conditions are presented in Tables 1-3. A significant main 
effect for day was found for all measurements: GRS-Orthoplast sphere (F3,48 = 44.26, P = .001), 
GRS-extension (F3,48 = 18.62, P = .001), and ROM (F3,48 = 13.40, P = .001). A significant day-
by-test interaction was found for GRS-extension (F3,48 = 5.04, P = .004) and ROM scores (F3,48 = 
19.77, P = .001). No significant differences were found for any of the group-by-test interactions: 
GRS-Orthoplast sphere (F1,16 = 0.74, P = .402), GRS-extension (F1,16 = 0.14, P = .717), and ROM 
(F1,16 = 0.96, P = 3.42). 
 
 
 
 
 
 
 
 
DISCUSSION 
The lack of controlled scientific study on the effectiveness of MENS for musculoskeletal trauma 
provided the rationale for this study. Our findings suggest that microcurrent treatment, at the 
selected parameters, was not effective in reducing pain and loss of ROM associated with DOMS. 
The lack of significant differences for pain and ROM scores between the treatment and sham 
groups also suggests the lack of placebo effect associated with microcurrent stimulation. 
 
We chose DOMS as a model for musculoskeletal injury for this experiment. We have used a 
DOMS model in our laboratory for numerous studies
7-12 
based on the similarity of DOMS to 
musculoskeletal trauma. DOMS is a condition characterized by pain, swelling, and loss of 
strength and ROM after unaccustomed eccentric exercise.
14,15
 Symptoms associated with DOMS 
usually increase in intensity during the first 24 hours after exercise and reach peak intensity 24 to 
72 hours postexercise.
15
 The significant change in pain and ROM measurements between days 
indicates that the protocol used in this experiment effectively induced DOMS. 
 
In previous DOMS studies, pain measurements have generally been collected as subjects actively 
extended the involved extremity as far as possible. The distinct loss of ROM associated with 
DOMS makes this task quite uncomfortable and provides 2 reasons for avoiding such a 
procedure. First, active elbow extension stretches the muscle, thereby affecting subsequent ROM 
measurements, and second, the discomfort created by active elbow extension could inhibit 
subsequent ROM. ROM measurements taken before pain measurements could also affect pain 
ratings. To avoid these effects, we chose to measure pain using the Orthoplast sphere before 
ROM measurements and then obtained a second pain measurement using active elbow extension 
immediately after ROM measurement. 
 
Much of the support for the use of microcurrent stimulation on musculoskeletal trauma is purely 
testimonial. Recently, researchers have begun experimenting with this modality to investigate its 
efficacy in musculoskeletal trauma. Their findings provide conflicting data. Denegar et al
8
 found 
that microcurrent treatment (100 µA at 0.3 Hz for 20 minutes) provided transient analgesia but 
did not significantly reduce the loss of strength associated with DOMS. Maurer et al
16
 reported 
less reduction in ROM after treatment with microcurrent stimulation at individual subsensory 
levels but concluded that MENS was not effective overall in the treatment of DOMS. Weber et 
al
14
 reported no significant difference among MENS, massage, upper body ergometry, and 
control treatments on DOMS. Finally, Rapaski et al
17
 found that MENS treatment at an intensity 
of 100 µA and individual subsensory levels was effective in reducing postexercise creatine 
kinase levels after the induction of DOMS. 
 
Previous authors have reported enhanced soft tissue healing
3-5 
and treatment of fracture 
nonunions
6
 after subsensory electrostimulation. Direct current stimulation was used in all 3 
studies
3-5 
and alternating current in only one.
3
 Bach et a1
3
 examined the biochemical and 
biomechanical effects of direct and alternating current subsensory stimulation on the healing of 
skin incisions. They reported an increase in collagen concentration in and around the wound 
(biochemical effect) and no difference in the tensile strength or wound thickness (biomechanical 
effects) when compared with control groups. MENS was delivered via an alternating current in 
our study. Therefore, the biochemical increases in collagen formation after MENS are 
advantageous but may not be reflected when clinical measures such as ROM and subjective pain 
measures are used. The conflicting results of the aforementioned studies demonstrate the need 
for further investigation of the efficacy of microcurrent stimulation before we can use it 
confidently as a treatment for musculoskeletal trauma. Further research should address the effi-
cacy of specific treatment parameters, including current, intensity, frequency, and treatment 
times, so that clinical applications can be identified. 
 
CONCLUSIONS 
At the parameters selected for this experiment, microcurrent stimulation was not effective in 
reducing pain and loss of ROM associated with DOMS. Additional research is needed before we 
can use microcurrent stimulation confidently in the sports medicine setting to reduce pain after 
musculoskeletal injury. 
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